RESUMO
BACKGROUND: Hepatocellular carcinoma (HCC) risk after resolving chronic hepatitis B virus (HBV) infection is unclear. AIM: To compare HCC risk between Alaska Native (AN) patients with and without hepatitis B surface antigen (HBsAg) seroclearance. METHODS: We selected persons with (case-patients) and without (control-patients) HBsAg seroclearance from a cohort of 1346 chronically HBV-infected AN patients followed during 1982-2013. We attempted to match two control-patients/case-patient on sex, HBV genotype, and age. Person-years of follow-up for case-patients began on the date of HBsAg resolution and for control-patients began on the date equivalent to the cohort entry date plus the years of HBsAg duration for their corresponding case-patient. We compared HCC risk using a Cox proportional hazards model. RESULTS: The 238 case-patients (4 with HCC) and 435 control-patients (9 with HCC) were similar in age [P-value (P) = 0.30], sex (P = 0.53) and HBV genotype (P = 0.99). Case-patients had longer person-years of follow-up than control-patients (11.7 vs. 10.1 years; P = 0.04). The HCC rate/100 000 persons was similar between case- (132) and control-patients (178; P = 0.65). The adjusted hazard ratio comparing case- and control-patients was similar for HCC [0.7; 95% confidence interval (CI): 0.2-2.4], increased for each 1-year increment for age (1.1; CI: 1.0-1.1; P < 0.01), and was greater if the initial HBeAg was positive (3.5; CI: 1.1-11.0; P = 0.03). CONCLUSIONS: Hepatitis B surface antigen seroclearance was not associated with reduced HCC risk; the HCC risk estimates are limited by wide 95% confidence intervals. Persons meeting HCC surveillance indications prior to HBsAg seroclearance could benefit from continued surveillance after seroclearance.
Assuntos
Carcinoma Hepatocelular/epidemiologia , Vírus da Hepatite B/genética , Hepatite B Crônica/complicações , Neoplasias Hepáticas/epidemiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos de Casos e Controles , Criança , Pré-Escolar , Feminino , Antígenos de Superfície da Hepatite B/imunologia , Antígenos E da Hepatite B , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Modelos de Riscos Proporcionais , Risco , Adulto JovemRESUMO
The Craig-Scott double upright knee ankle orthosis was subjected to a biomechanical evaluation which included analysis of the force interaction with the supported limb and a functional evaluation. The results were compared with data previously determined from biomechanical evaluations of other common orthoses. In the Craig-Scott design, the single application of the knee stabilizing force below the knee concentrates this force in a relatively small bony area, sometimes exceeding tolerance. This might be avoided by using a tibial closure with patellar tendon bearing features. The design was found to produce relatively low anatomic knee shear. In functional aspects such as donning, doffing, transfers and ambulation, the orthosis is essentially equivalent to other double upright designs. The rigidity of the orthosis with only a tibial band closure and a bail connecting the uprights was determined to be adequate. The limited number of bands and closures provides some advantages in reduced donning and doffing time; however, in the absence of posterior closures below the knee, the orthosis had a tendency to slide forward off the leg when transferring. This disadvantage was eliminated by adding a soft posterior closure below the knee, which produced a minimal increase in donning and doffing times.